Sponsored Post

MedCity Spotlight Video: Fredrikson & Byron attorneys discuss Covid-19’s impact on deal-making and value-based care [Sponsored]

In a Spotlight Video interview, Fredrikson & Byron Shareholders and Co-chairs of the firm’s life sciences group, Jeff Steinle and Ryan Johnson, talked about the deal-making environment in healthcare and how the Covid-19 pandemic has impacted it. 

Leading hardtech innovation center mHUB opens MedTech accelerator for medical device startups [Sponsored]

The mHUB MedTech Accelerator is a six-month program, based in Chicago, run in partnership with Baxter and Edward-Elmhurst Health Venture Capital. The application deadline is Monday, August 23.

Regulated digital health explained: What you need to know to stay compliant [Sponsored]

Digital health thought leader Mark Tarby, BrightInsight vice president of regulatory and quality management systems, shared his take on what the EU MDR means for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.

Pediatric Device Innovators Forum Explores State of Focused Ultrasound [Sponsored]

This free livestream event, hosted by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), features clinical, regulatory and reimbursement experts discussing the topic “Focused Ultrasound for Pediatric Indications.”

MedCity Spotlight Video: Fruit Street Health on diabetes and telemedicine [Sponsored]

Although it has focused on diabetes management, Founder and CEO Laurence Girard says that the company is growing its telemedicine services to include virtual primary care support for other chronic conditions such as hypertension, mental health and smoking cessation that pair community and clinical components.

INVEST Video Conference: What is the role of AI in health equity? [Sponsored]

With artificial intelligence and machine learning algorithms are becoming more in vogue in different aspects of healthcare, our panel discusses how can we ensure that AI is leveraged properly so that it advances the goals of health equity.

MedCity Spotlight Video: How Penn Center for Innovation is combating Covid-19 [Sponsored]

As part of MedCity’s 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has developed to detect SARS-CoV-2 and how the platform technology can be deployed to detect other diseases cost-effectively.

How are healthcare organizations shifting to digital documents? [Sponsored]

In order to gain insight into how organizations are thinking about digitizing medical documents and the strategy behind those decisions, we’re conducting a brief survey of the MedCity News audience and will publish a report based on this survey’s findings.

Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021? [Sponsored]

Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.

Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation  [Sponsored]

Cho discusses Bristol Myers Squibb’s research efforts in the field of protein degradation to advance potential treatments for a broad range of diseases. In a recent MedCity Pivot Podcast, he also shared insights on his approach to drug discovery, perspectives on dealing with failure, and some of the work his teams are doing in the …

Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation  [Sponsored] Read More »

In MedCity Pivot podcast, biopharma researcher talks about protein degradation, recent success tied to Covid-19 [Sponsored]

Ho Sung Cho, senior vice president of Biodiscovery Therapeutics at Bristol Myers Squibb, talks about lessons learned from drug discovery, recent success tied to Covid-19, and how the company is leveraging its expertise in protein degradation to develop novel therapies for blood cancers, solid tumors and other important therapeutic areas.

How digital health impacts the development and adoption of cancer immunotherapies [Sponsored]

In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.

Push for better patient outcomes drives new standard of care [Sponsored]

In this webinar on Feb. 10,healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.

What’s needed to make consumerization of healthcare work for patients? [Sponsored]

As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has never been more critical. A new guide from Bright.MD offers a digital checklist on how to improve the patient experience.

Covid-19’s terrible toll on diabetes patients. What can be done? [Sponsored]

The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. A validated program that can effectively help people manage their disease is invaluable, especially at a time when in-person physician visits are unavailable.

Transforming the patient experience to enable informed healthcare decisions [Sponsored]

Although the Covid-19 pandemic has had a significant impact on healthcare delivery, in many ways it has underscored the need for a healthcare system that can help patients easily navigate healthcare concerns as well as price transparency.

How is population health innovation unfolding in Louisiana? [Sponsored]

With the annual INVEST Population Health virtual conference coming up November 16-18, here’s a look at our collaboration partner New Orleans Business Alliance. It plays a vital role in helping to stimulate the local economy by supporting the development and advancement of the healthcare and biotech infrastructure.

Using digital engagement to solve pain points along the patient journey: How to deliver better outcomes for patients and brands [Sponsored]

Join us November 10th to learn how digital engagement can solve challenges for both patients and the brand and learn other benefits that will improve patient experience and address multiple barriers to medication adherence.

J.P. Morgan on the state of life sciences and strategies to fuel innovation [Sponsored]

In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has cast a bright light on the life sciences industry with startups raising venture funding at record levels as the virus has transformed the way people usually do business in the sector. 

Bind personalized health plan outperforms industry benchmarks for total cost [Sponsored]

When employers offer a health plan with clear pricing, their employees are more likely to consistently choose higher-value, lower-cost care, according to a new Bind analysis using industry-leading national commercial benchmark and risk adjusted data. Register here to hear more.

How can life science companies benefit from hiring a Professional Employer Organization? [Sponsored]

In an interview, TriNet’s Vice President of Life Sciences, Maria Abouseif, talked about the role Professional Employer Organizations play in helping life science companies navigate the COVID-19 public health crisis.

A special presentation from J.P. Morgan for MedCity’s INVEST conference [Sponsored]

Pamela Aldsworth, head of VC coverage and managing director at J.P. Morgan, discusses deals and dealmaking during the pandemic and how startups can survive, in a special presentation to mark MedCity News’ annual INVEST conference.